Doctors in South Africa have found that chemotherapy is no longer effective in treating dermatillomens’ most common cause of serious, life-threatening disease, according to a report from CNN Medical.
The condition is often called “dry skin,” but dermatilloms commonly describe it as “dry, wrinkled skin.”
Doctors believe it’s because the immune system is less sensitive than in the rest of the body, which makes the skin more susceptible to infections and infections-causing chemicals.
But they can’t yet prove that the disease is caused by chemical exposure.
The disease is a common side effect of chemotherapy, and many dermatillomas cause chronic fatigue and other side effects.
The new study, published in the Journal of the American Academy of Dermatology, says dermatilloma patients in the study who received an average of three chemo doses per week had significantly reduced levels of melanin in their skin.
“This suggests that a number of factors might be contributing to the reduced melanin levels,” Dr. Piers J. Diamant, an assistant professor of dermatology at Emory University School of Medicine in Atlanta, said in a statement.
The study found that melanin is a critical component of the skin’s protective barrier, which is essential for our skin’s ability to protect us from ultraviolet light and the damaging effects of free radicals.
And melanin also plays a role in protecting our immune system, the researchers wrote.
The researchers did not find any side effects of the chemotherapy treatment.
“A few patients did experience some side effects,” Diaman said.
“However, these were mild and the majority of the patients reported that they had not experienced any side effect.”
The study also did not prove that melanoma patients were more likely to get the disease from exposure to chemicals, and the researchers said that more studies are needed to examine this question.
“The study does not provide definitive proof of an association between chemo treatment and the incidence of melanoma,” Dr the researchers added.